PULMONX CORPORATION
Who is PULMONX CORPORATION?
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of th...See more
Industry & Specialities
Manufacturing
Countries of Operation
Australia United States of America
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
201-500 Employees
Address:
700 CHESAPEAKE DRIVE,; REDWOOD CITY, CA 94063, US
Employees by Department
- Sales (6)
- The Rest (-1)
- Total (5)
Key Decision Makers
Ben M
Market Development Manager SA/WA
Janine Pallas
Market Development Manager
Robyn Flynn
Market Development Manager
Ruth Patterson
Market Development Manager NSW/ACT
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
0employees
Senior
0employees
Non-managers
0employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- Fast Growing SMEs
- Companies with Recent Funding > 100K
- Companies with High Spending Power
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of PULMONX CORPORATION?
- Where is PULMONX CORPORATION's headquarter?
- What PULMONX CORPORATION's spending power?
- Does PULMONX CORPORATION have a presence in the domain it operates in?